lumacaftor,
VX 809,
VX-809,
936727-05-8,
Lumacaftor,
VX-809,
VX809,
VX 809,
VRT-826809,
VRT 826809,
3-(6-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid,
UNII-EGP8L81APK,
VX-809 (Lumacaftor),
EGP8L81APK,
3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-benzoicacid,
3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-benzoic acid,
AK-36922,
3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]benzoic acid,
3-(6-{[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropane-1-carbonyl]amino}-3-methylpyridin-2-yl)benzoic acid,
3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-be,
3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)benzoic acid,
Lumacaftor [USAN:INN],
3-(6-[[1-(2,2-DIFLUORO-BENZO[1,3]DIOXOL-5-YL)-CYCLOPROPANECARBONYL]-AMINO]-3-METHYL-PYRIDIN-2-YL)-BENZOIC ACID,
Lumacaftor (USAN),
PubChem22450,
MLS006011120,
SCHEMBL377028,
Lumacaftor(vx-809 vx809),
GTPL7481,
CHEMBL2103870,
CHEBI:90951,
CTK8B5597,
AOB2051,
DTXSID30239523,
EX-A178,
C24H18F2N2O5,
UFSKUSARDNFIRC-UHFFFAOYSA-N,
HMS3655E05,
BCP02305,
ABP000707,
ANW-49250,
MFCD16659051,
s1565,
VX-809/VX809,
ZINC64033452,
AKOS015920205,
API0007686,
CS-0479,
DB09280,
PB19466,
QC-7245,
NCGC00346550-01,
NCGC00346550-05,
3-(6-(1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxamido)-3-methylpyridin-2-yl)benzoic acid,
4CA-0760,
AC-23172,
AN-16986,
AS-31756,
BC660192,
Benzoic acid, 3-(6-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-3-methyl-2-pyridinyl)-,
BR-36922,
EN002684,
HY-13262,
SC-95543,
SMR004702901,
AB0008169,
AJ-114588,
AX8160252,
TC-137995,
FT-0757817,
ST24028315,
SW219911-1,
W9631,
A25628,
D10134,
S-5955,
J-690399,
VX809, VX 809, 936727-05-8,
3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid,
3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carboxamido)-3-methylpyridin-2-yl)benzoic acid,
3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]amino}-3-methyl-pyridin-2-yl)benzoi,
3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]amino}-3-methyl-pyridin-2-yl)benzoic acid,
3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoic acid VX 809 Lumacaftor,
3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methyl-2-pyridyl]benzoic acid,
3-{6-[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropaneamido]-3-methylpyridin-2-yl}benzoic acid,
3-{6-[1-(2,2-difluoro-2H-1,3-benzodioxol-5-yl)cyclopropaneamido]-3-methylpyridin-2-yl}benzoic acid,
Lumacaftor [INN],
1,2-EPOXYOCTANE,
ACN-036619,
A8351,
A10986,
C569105,
2-(1-Propylpiperidin-4-yl)-1H-benzo[d]imidazole-7-carboxamide succinate,